Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis
Xue Li, Xianchao He, Leyan Zhang, Zhigang Li, Yuanyuan Liu · 2025
Read Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis by Xue Li, Xianchao He, Leyan Zhang, Zhigang Li, Yuanyuan Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12776217.txt.
Description
Xue Li, Xianchao He, Leyan Zhang, and a wider team wrote this research paper, published in 2025. It shows that a plant compound, demethylzeylasteral, can kill myeloid leukemia cells by overloading their protein-folding machinery until they self-destruct.
The compound comes from a traditional medicinal plant and had shown anti-tumor effects elsewhere. The team screened sixty-five related compounds, then treated leukemia cells with the winner. Treated cells stopped dividing and died in rising numbers. Gene readouts pointed at the cell's unfolded-protein alarm chain, running through the named signaling steps to a death switch. Blocking links in that chain blunted the drug, confirming the route. In mice carrying human leukemia grafts, the compound slowed the disease. The authors propose it as a lead for a cancer short on new drugs.
Catalog record
| CREATOR | Xue Li, Xianchao He, Leyan Zhang, Zhigang Li, Yuanyuan Liu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |